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Chemistry, University of Cincinnati, 301 Clifton Ct, Cincinnati, OH 45221, USA, 5 Department of Biochemistry,
Washington University, St. Louis, MO, USA and 6 Departments of Cancer Biology and Molecular & Cellular Oncology,
University of Texas, MD Anderson Cancer Center, Houston, TX 77030, USA

2

Received June 06, 2020; Revised November 21, 2020; Editorial Decision November 23, 2020; Accepted December 13, 2020

ABSTRACT
The XRCC1–DNA ligase III␣ complex (XL) is critical
for DNA single-strand break repair, a key target for
PARP inhibitors in cancer cells deficient in homologous recombination. Here, we combined biophysical
approaches to gain insights into the shape and conformational flexibility of the XL as well as XRCC1 and
DNA ligase III␣ (LigIII␣) alone. Structurally-guided
mutational analyses based on the crystal structure
of the human BRCT–BRCT heterodimer identified the
network of salt bridges that together with the Nterminal extension of the XRCC1 C-terminal BRCT
domain constitute the XL molecular interface. Coupling size exclusion chromatography with small angle X-ray scattering and multiangle light scattering
(SEC-SAXS–MALS), we determined that the XL is
more compact than either XRCC1 or LigIII␣, both of
which form transient homodimers and are highly disordered. The reduced disorder and flexibility allowed
us to build models of XL particles visualized by negative stain electron microscopy that predict close spatial organization between the LigIII␣ catalytic core
and both BRCT domains of XRCC1. Together our
results identify an atypical BRCT–BRCT interaction
as the stable nucleating core of the XL that links
the flexible nick sensing and catalytic domains of

LigIII␣ to other protein partners of the flexible XRCC1
scaffold.
GRAPHICAL ABSTRACT

INTRODUCTION
The DNA repair gene XRCC1 was first identified in a screen
of human cDNAs that complemented the alkylation and
X-ray sensitive phenotypes of the mutant Chinese Hamster Ovary cell line EM9 (1). Besides DNA damage sen-
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tions that are independent of LigIII␣ (43–45). In contrast,
LigIII␣ is essential for mitochondrial DNA metabolism but
XRCC1 is not present in these organelles (21,23,46,47).
For these various XRCC1 biological functions, it is important to understand the XRCC1 architectural structure
and its relationship to its scaffolding functions. Since the
C-terminal BRCT domains of XRCC1 and LigIII␣ can
form homodimers (48,49), we reasoned that these proteins
may function as homodimers as well as heterodimers. Yet,
although the structure of a hybrid complex between human L3BR and mouse X1BR2 has been determined (48),
the structure of full-length complexes of dimeric XRCC1
and XRCC1-LigIII␣ (XL) are unknown. Here, we solved
the crystal structure of human L3BR complexed with human X1BR2 and furthermore define the architectures and
structural flexibility of human XRCC1, LigIII␣ and the
XL heterodimer by combining small-angle X-ray scattering
(SAXS) and electron microscopy (EM).
MATERIALS AND METHODS
Protein expression and purification
Full-length XRCC1 and LigIII␣ [in pRSFduet (Novagen)]
and XRCC1N [residues 294–633 in pET32a (Novagen)]
were expressed in Escherichia coli Rosetta cells, and purified using the same protocol as LigIII␤ described previously (50). L3BR (residues 825–922) and X1BR2 (residues
538–633) domains were expressed from pET28a with Nterminal His-tag in E. coli Rosetta cells. After Ni-NTA
(Qiagen) affinity chromatography, proteins were purified
by Superdex 200 (GE Healthcare) size exclusion column.
For pull-down assay, L3BR, X1BR2 and X1BR1 (residues
294–417) were cloned into pGEX-6p1 (GE Healthcare).
GST-tagged L3BR, X1BR2 and X1BR1 were expressed
in E. coli Rosetta cells. After glutathione-sepharose chromatography (GE Healthcare), proteins were further purified by Superdex 200 column. X1BR1 was further purified
by Sephadex 100 (GE Healthcare) after GST-X1BR1 was
cleaved with precission protease. GFP- and MBP-tagged
X1BR1 and L3BR were expressed from pET28a with Nterminal His-tag in E. coli Rosetta cells and purified using Ni-NTA affinity chromatography, followed by Superdex
200 size exclusion chromatography.
For crystallization, L3BR (residues 844–922 with C922S
mutation) and X1BR2 (residues 538–633) were fused by a
22-amino acid flexible linker containing a His-tag and precission protease cleavage site, and the fusion protein was expressed in E. coli Rosetta cells. The L3BR-X1BR2 fusion
protein was cleaved by purified precission protease after NiNTA column, and then further purified by Superdex 200
column. Selenomethionine labeled L3BR-X1BR2 fusion
protein was expressed in Rosetta cells using amino acids
to suppress methionine biosynthesis, as described (51), and
was purified by the same protocol as the native protein. Protein crystallization conditions and structure determination
methods are described in Supplementary Material.
Full-length XRCC1-LigIII␣ and XRCC1 were purified
from insect cells after infection with baculoviruses encoding
streptactin-tagged LigIII␣ and His-tagged XRCC1 (52,53).
The XL complex was purified sequentially by HisTrap HP
(GE Healthcare), Superdex 200 16/60 (GE Healthcare) and
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sitivity, a hallmark feature of these cells is a high spontaneous level of sister chromatid exchanges, indicative of hyperrecombination (1). XRCC1 protein lacks enzymatic activity; yet, it plays a key role in multiple DNA repair pathways by acting as a scaffold that binds to both DNA single
strand breaks and gaps, poly (ADP-ribose) and to numerous DNA repair enzymes (2). DNA ligase III␣ (LigIII␣)
was the first XRCC1-interacting protein to be identified
(3), and is critical to bridge two DNA ends to promote
specific intermolecular DNA end joining (4). This was followed by DNA glycosylases (5–10), AP endonuclease 1 (11),
and DNA polymerase ␤ (Pol␤) (12,13), implicating XRCC1
in coordinating observed product complexes (14) for the
short patch subpathway of base excision repair. An interaction with automodified PARP1 serves to recruit XRCC1
and other interacting proteins that also include the endprocessing enzymes, polynucleotide kinase phosphorylase
(PNKP) (15), aprataxin (APTX) (16) and APLF (17) to
DNA single strand breaks (18–20). While these proteinprotein interactions and the phenotype of xrcc1 cells show
XRCC1 is a key factor in single-strand break repair (SSBR),
other SSBR and base excision repair (BER) pathways involving DNA ligase I (LigI) and other DNA replication
proteins are at least partially functionally redundant (21–
24). This redundancy between LigI- and LigIII␣-dependent
subpathways also occurs in nucleotide excision repair and in
back-up pathways of DNA double-strand break repair, also
known as alternative end joining (25–27).
XRCC1-deficient cells have reduced steady-state levels of
both Pol␤ and LigIII␣, indicating that XRCC1 interactions
promote the stability of these DNA repair enzymes along
with their recruitment to DNA damage sites (28,29). In contrast, the steady-state levels of the other XRCC1-interacting
proteins appear unaffected by XRCC1 absence. Interestingly, the binding sites for XRCC1-interacting proteins appear to be arranged linearly along the XRCC1 polypeptide with Pol␤ interacting with the N-terminal region and
LigIII␣ with the C-terminal region (2). While most binding
regions appear non-overlapping, enabling XRCC1 to assemble multiprotein complexes, PNKP, MRE11, aprataxin
and APLF binding sites are mutually exclusive and dependent upon XRCC1 phosphorylation, explaining the detection of distinct XRCC1 complexes containing either PNKP
or aprataxin (2,15,17,30–34). Interestingly, mutations in
the genes encoding XRCC1, PNKP and aprataxin are the
causative factor in inherited neurodegenerative diseases,
indicating that XRCC1-dependent repair of single strand
breaks with non-ligatable ends plays a key role in neuronal
cells (35–37).
Three folded domains have been identified within
XRCC1 (Figure 1A); an N-terminal domain that interacts with Pol␤ (38), a central BRCT domain (X1BR1) that
interacts with poly(ADP-ribosyl)ated (PARylated) PARP1
(18,39) and a C-terminal BRCT domain (X1BR2) that
interacts with the C-terminal BRCT domain of LigIII␣
(L3BR) (40–42). While inactivation of the central X1BR1
domain results in DNA damage hypersensitivity due to a
defect in S phase-dependent DNA repair, disruption of the
interaction between the C-terminal BRCTs of XRCC1 and
LigIII␣, which results in destabilization of LigIII␣, does
not, indicating that XRCC1 has nuclear DNA repair func-
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Figure 1. Human BRCT–BRCT heterodimer structure stably links XRCC1 and LigIII␣ via a mutationally verified interface. (A) Domain organization of
human XRCC1 and LigIII␣ with the C-terminal BRCT domains used for crystallization (red and blue-boxes) (B) GFP-fluorescence-based competition
assay (see Supplementary Figure S3) measuring specific binding affinity of L3BR832 and L3BR844 for X1BR2. The data shown represent the mean values
and standard deviations from three independent experiments. (C) Structure of human XLBR-BR complex (X1BR2, blue; L3BR, red) is superimposed on
to previously reported structures of heterodimers between mouse X1BR2 and human L3BR with two different lengths of N-stretch region. The different
lengths of N-stretch regions of X1BR2 and L3BR constructs are highlighted. The XLBR-BR interfaces, which are classified based on the location and
main type of interaction [electrostatic (E region, top, green), hydrophobic (H region, middle, purple) and polar (P region, bottom, blue) interactions], are
indicated. (D) Panels show close-up of three main binding interfaces between X1BR2 and L3BR. (E) Effects of substituting residues that are located at
the BRCT–BRCT interface on X1BR2–L3BR complex formation measured by native gel analysis; upper left panel, substitution of amino acids in the E
region; upper right panel, substitution of Leu847 of L3BR, an equivalent of Leu539 of X1BR2; lower panel, substitution of amino acids in the H and P
regions of the binding interface. The X1BR-only and L3BR-only control reactions are shown in the leftmost and rightmost lane of each gel, respectively.
For residues in E region (upper left panel) or H and P regions (lower panel), gels were run with negative control (X1BR2 or L3BR alone) and positive
control (with wild-type X1BR2, WT) reactions, and then combined in a single panel to compare their effects on L3BR binding. Representative gels from
two independent experiments are shown. Since the theoretical pI for L3BR is 9.22 compared with 4.90 for X1BR2, L3BR does not enter the gels, which
are run at pH 7.5, unless it is complexed with X1BR2.

Nucleic Acids Research, 2021, Vol. 49, No. 1 309

dsDNA cellulose (Sigma Aldrich) column chromatography.
6His-XRCC1 was purified sequentially by HisTrap HP and
Superdex 200 16/60 column chromatography.

In a fluorescence-based competition assay, GST-L3BR (7
M) and X1BR2-GFP (8 M) were pre-incubated in a
buffer containing 50 mM Tris–HCl pH 7.5, 150 mM NaCl,
10% glycerol and 2 mM DTT for 20 min on ice, and complexes were immobilized to GSH-coated magnetic beads
(Promega). The beads were washed three times with the
same buffer. The pre-bound complexes were competed off
by adding MBP, MBP-L3BR832 and MBP-L3BR844 (0–25
M). After the beads were pelleted using a magnet, the release of the X1BR2-GFP was monitored by the increased
GFP fluorescence of the supernatant in 96-well plates using
Synergy-2 microplate reader (BioTek).
To confirm the predicted key role of specific amino acids
in the heterodimer interface, mutant versions of X1BR2
(residues 538–633) and L3BR (residues 825–922) were
made using the Quickchange site-directed mutagenesis kit
(Stratagene). Due to the high tendency of X1BR2 to aggregate in the absence of L3BR, we changed Leu626 in the
C-terminus of X1BR2, which contributes to crystal packing interactions in both X1BR2 and the XLBR–BR complex
structure (data not shown) to Glu. Since this substitution
did not affect L3BR binding and it also significantly reduced aggregation, it was designated as wild type (WT) in
Figure 1E and used as the template for further mutational
analyses. Mutant proteins were expressed and purified by
the same protocol as the native protein. Purified X1BR2 (8
M) and L3BR proteins (0–12 M) were incubated in 20
l binding buffer (50 mM Tris–HCl pH 7.5, 150 mM NaCl,
2 mM DTT and 10% glycerol) for 30 min at 22◦ C. Samples
were separated by electrophoresis on a native 10% polyacrylamide gel as described by Kang et al. (54).
Multi-angle light scattering coupled to size-exclusion chromatography
SEC-MALS was carried out either in parallel with SAXS
(see below) or stand-alone. For stand-alone SEC-MALS,
XRCC1 and the XL complex were injected at 0.35 ml/min
with an AKTAmicro (GE Healthcare) onto a Superdex
200 Increase 10/300 GL column equilibrated in 40 mM
HEPES pH 7.5, 200 mM NaCl, 10% glycerol and 0.1
mM TCEP. Molecular masses were determined using the
Dawn HELEOS II MALS and OptiLab T-rEX online refractive index detectors (Wyatt Technology). The detectors
were calibrated with the BSA monomer and data processed
with ASTRA Version 6.1.6.5 (Wyatt Technology). The sizeexclusion column was calibrated using protein standards
(Bio-Rad).
Small angle X-ray scattering
SAXS was performed at the SIBLYS beamline at the Advanced Light Source (55,56). For SAXS coupled with multiangle light scattering in line with size-exclusion chromatography (SEC-SAXS-MALS) experiments, 60 l containing
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either 4.3 mg/ml 6His-XRCC1 in 200 mM NaCl, 20 mM
Tris–HCl pH 7.5 , 2% glycerol (Figure 2); 5.96 mg/ml StrpLigIII␣/6His-Flag-XRCC1 in 50 mM Tris–HCl pH 7.5, 100
mM NaCl, 5 mM MgCl2 , 0.2 mM PMSF, 1 mM benzamidine (Figure 5). SEC-SAXS-MALS were collected at
the ALS beamline 12.3.1 LBNL Berkeley, California. Xray wavelength was set at  = 1.127 Å and the sample-todetector distance was 2100 mm resulting in scattering vectors, q, ranging from 0.01 to 0.4 Å–1 . The scattering vector
is defined as q = 4sin /, where 2 is the scattering angle. All experiments were performed at 20◦ C and data was
processed as described (57). Briefly, a SAXS flow cell was directly coupled with an online Agilent 1260 Infinity HPLC
system using a Shodex KW804 or Superdex 200 300/10 column giving similar SAXS results for Strep-LigIII␣/6HisFlag-XRCC1. The column was equilibrated with running
buffer as indicated above with a flow rate of 0.5 ml/min.
55 l of each sample was run through the SEC and three
second X-ray exposures were collected continuously during
a 30-min elution. The SAXS frames recorded prior to the
protein elution peak were used to subtract all other frames.
The subtracted frames were investigated by radius of gyration (Rg ) derived by the Guinier approximation I(q) = I(0)
exp(–q2 Rg 2 /3) with the limits qRg < 1.5 (58). The elution
peak was mapped by comparing the integral of ratios to
background and Rg relative to the recorded frame using the
program SCÅTTER. Non-uniform Rg values across an elution peak represent a heterogeneous assembly. Final merged
SAXS profiles, derived by integrating multiple frames at
the peak of the elution peak, where used for further analysis including Guinier plot which determined aggregation
free state. The program SCÅTTER was used to compute
the pair distribution function (P(r)). The distance r where
P(r) approach zero intensity identifies the maximal dimension of the macromolecule (Dmax ). P(r) functions were normalized based on the molecular weight of the assemblies
as determined by SCÅTTER using volume of correlation
Vc (59). Eluent was subsequently split 3 to 1 between the
SAXS line and a series of UV at 280 and 260 nm, multiangle light scattering (MALS), quasi-elastic light scattering
(QELS) and refractometer detectors. MALS experiments
were performed using an 18-angle DAWN HELEOS II light
scattering detector connected in tandem to an Optilab refractive index concentration detector (Wyatt Technology).
System normalization and calibration was performed with
BSA monomer using a 45 l sample at 10 mg/ml in the
same SEC running buffer and a dn/dc value of 0.19. The
light scattering experiments were used to perform analytical
scale chromatographic separations for Mw determination of
the principle peaks in the SEC analysis. UV, MALS, and
differential refractive index data was analyzed using Wyatt
Astra 7 software to monitor the homogeneity of the sample across the elution peak complementary to the abovementioned SEC-SAXS signal validation.
Full-length LigIII␣, XRCC1N, phosphorylated
XRCC1N (XRCC1N-p), L3BR, X1BR2 and
XRCC1N-p/L3BR complex samples were dialyzed
with a buffer containing 25 mM Tris–HCl pH 7.5, 150
mM NaCl, 10% glycerol and 2 mM DTT. SAXS data
were collected at three different concentrations on the
ALS beamline 12.3.1 LBNL Berkeley, California in high-
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Solution structure modeling
An initial atomistic model of XRCC1N was built by connecting the NMR structure of X1BR1 (PDB ID: 2D8M)
and our crystal structure of X1BR2 by MODELLER (61).
A full length atomistic model of XRCC1 was built by
connecting NMR structure of XRCC1 N-terminal domain
(PDB ID: 1XNA) (62) to the XRCC1N model. An initial
homology model of full length LigIII␣ was built based on
the crystal structure of LigIII␤ (PDB ID: 3L2P) (63), the
NMR structure of the N-terminal zinc finger (ZnF; PDB
ID: 3OD8) (64) and our crystal structure of the C-terminal
L3BR domain by connecting the regions with linkers modeled by MODELLER (61). Two initial atomistic models of
dimeric XL complexes were built by adding missing linkers into two EM-derived conformers (see below). Minimal
molecular dynamics (MD) simulations were performed on
flexible regions in the models by the rigid body modeling
strategy BILBOMD in order to optimize the conformational space of domain linkers alone (XL complex) or individual domains (XRCC1N, XRCC1, LigIII␣ and XL
complex) (65). The experimental SAXS profiles were then
compared to theoretical scattering curves generated from
atomistic models using FOXS (66,67) followed by multistate
model selection by MultiFOXS (68).
Crosslinking, negative-stain electron microscopy and image
analysis
Chemical crosslinking of XRCC1 and the XL complex
(dsDNA-cellulose-purified) was carried out in the dark, on
ice, for 5 min with 0.05% (v/v) glutaraldehyde in 40 mM
HEPES pH 7.5, 200 mM NaCl, 10% glycerol. Reactions
were quenched with 1 M Tris pH 7.5 and buffer exchanged
to EM buffer (40 mM HEPES pH 7.5, 50 mM NaCl, 0.1
mM TCEP). Crosslinked and non-crosslinked samples were
diluted in EM buffer and deposited onto glow-discharged
(Agar Scientific) carbon-coated copper grids (Electron Microscopy Sciences) for 1 min before blotting excess liquid
with Whatman No. 1 filter paper. Freshly-prepared uranyl
formate (1.5%; Electron Microscopy Sciences) was immediately applied for 1 min, followed by blotting excess liquid and air drying. Micrographs were collected using a FEI
Tecnai T12 transmission electron microscopy fitted with a
LaB6 filament and operated at 120 keV at room temperature. Low-dose mode was implemented in SerialEM (69) to
acquire images at 67 000× magnification (corresponding to
a pixel size of 1.64 Å) using a FEI Eagle 4k × 4k CCD camera with defocus values between 0.5 and 2 m.
Image processing was carried out with the Scipion framework (70). None of the processing steps corrected for con-

trast transfer function nor applied symmetry. Automatic
particle-picking using a reference-free algorithm (71) resulted in 78,400 coordinates of XRCC1 (non-crosslinked)
and 12,700 coordinates of the crosslinked XL complex. Particles were extracted with two-fold downsampling in 264
Å boxes. Bad picks were discarded through iterative 2D
classification using CL2D from Xmipp (72).The XL dataset
was pruned to remove non-XL particles, resulting in 7648
particles that were used to generate an initial model through
a stochastic gradient descent algorithm (73). The initial
model was low-pass filtered to 60 Å and used for 3D classification (74) into three classes using a 200 Å circular mask.
Classes 1 and 3 (31% and 28%, respectively) were grouped
based on their overall similarity and the resulting merged
class 1 (low-pass filtered to 60 Å) was refined using the
grouped particles without applying a mask (EM conformer
1). Class 2 (41% of particles) was refined separately (EM
conformer 2). The resolutions of the XL complex conformers were determined using the gold-standard Fourier shell
correlation at the 0.5 criterion (75). Crystal and solution
structures were docked into the EM maps using UCSF
Chimera (76).
RESULTS
Human XRCC1 and DNA ligase III␣ C-terminal BRCT domains determine homodimer and heterodimer formation
XRCC1 and LigIII␣ are elongated, multidomain proteins
that form a stable complex through interactions between
their C-terminal BRCT domains (48,49,63) (Figure 1A).
While there is significant evidence that the XL complex is
a key factor in BER and SSBR, the ability of these proteins to also form homodimers that may have specific functions (21,23,43,44,48,49), raises questions about the mechanisms that underlie formation of heterodimers and homodimers. In initial size exclusion experiments with the purified
BRCT domains of human XRCC1 and LigIII␣, L3BR832
(residues 832–922) expressed either as an N-terminal MBPfusion protein (Supplementary Figure S1A) or fused to Cterminal GFP (Supplementary Figure S1B) forms a dimer,
whereas the dimerization of X1BR2 fused to C-terminal
GFP appears to be transient under these conditions, consistent with the reported concentration-dependent dimerization of XRCC1 (49). Notably, deletion of 12 N-terminal
residues from L3BR832 results in the MBP-fusion protein
behaving as a monomer (Supplementary Figure S2A). Despite efficient homodimerization, untagged L3BR832 readily formed a 1:1 complex with MBP or GFP-tagged X1BR2
(Supplementary Figure S2). This finding suggests that the
N-terminal linker region of L3BR (residues 832–843) is
important for homodimerization but is dispensable for
heterodimerization. Notably, in all size-exclusion chromatography experiments, the formation of heterodimers of
X1BR2 and L3BR was considerably more favorable than
homodimerization (Supplementary Figure S2).
To measure the apparent dimerization affinity of BRCT–
BRCT interactions, a GFP-fluorescence-based, competition binding assay was developed (see Materials and Methods and Supplementary Figure S3). For this assay, GSTtagged L3BR832 was immobilized on glutathione-coated
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throughput (HT) mode (60). Incident X-rays were tuned to
a wavelength of  = 1.0 Å at a sample-to-detector distance
of 1.5 m, resulting in scattering vectors (q) ranging from
0.01 to 0.31 Å−1 . All experiments were performed at 10◦ C
and data was processed as described (55). Briefly, the data
were acquired at short and long-time exposures (0.5 s, 5 s)
then scaled and merged to obtained interference free SAXS
profile. Further data processing was identical with process
described for SEC-SAXS merged profiles.
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BRCT heterodimer atomic resolution structure
We solved and refined the human X1BR2–L3BR844 complex (XLBR–BR ) structure at 2.4 Å resolution (Supplementary Table S1, Figure 1C and Supplementary Figure S4).
Overall, the structure of this complex resembles the previously reported hybrid complex between human L3BR and
mouse X1BR2 (48) (Figure 1C). In the human XLBR–BR
complex, there is a V-shaped ‘head-to-head’ arrangement of
interacting L3BR–X1BR2 domains that buries 1164 Å2 of
solvent accessible surface. Complementary surfaces of the
BRCT domains are mostly contributed by helix ␣1 and the
proximal ‘␣1-␤2 loop’, together with a short N-terminal extension (N-stretch) from each BRCT domain (Figure 1C).
In comparison with the hybrid XLBR–BR structure, there
is an increase in the tilt angle between L3BR and X1BR2
domains in the human structure. Notably, the structure of
the hybrid XLBR–BR heterodimer with a longer X1BR2 Nstretch (Figure 1C, cyan, PDB ID: 3QVG) is more compact than the human XLBR–BR complex with a shorter Nstretch region (Figure 1C, red/blue), suggesting that an additional electrostatic interaction between the X1BR2 Nstretch residue Asp531 and L3BR residues Arg914 and
Lys915 contributes to compaction of the complex (Figure
1C and Supplementary Figure S5). However, there are also
differences in the main interaction interface between the
similar-length hybrid XLBR–BR (PDB ID: 3PC8) (48) and
the human complex, presumably reflecting differences in the
amino acids of mouse and human X1BR that contribute to
the interface.
In the human complex, three protruding side chains of
X1BR (Leu539 from the N-stretch and Arg560 and Arg564
from helix ␣1) contact the hydrophobic C-terminal half of
␣1 in L3BR (Figure 1D). Together they make a network
of electrostatic interactions with nearby residues Asp849,
Asp876 and Asp878 of L3BR. Similar, but not strictly
equivalent, reciprocal interactions are made by analogous
residues of L3BR. Leu847 within the N-stretch of L3BR
and Arg870 from ␣1 contact the hydrophobic C-terminal
half of ␣1 and its proximal surfaces of X1BR2 (Figure 1D).
Overall, the two BRCT domains are interlinked by protruding Leu and Arg residues from each subunit that stabilize

the human XLBR-BR heterodimer by a combination of electrostatic (E region), hydrophobic (H region) and polar interactions (P region) (see Figure 1C and D). In the E region,
Arg560 and Arg564 from ␣1 of X1BR2 form a network
of salt bridges with Asp849, Asp876 and Asp878 residues
from L3BR (Figure 1D). In addition, Arg564 from ␣1 of
X1BR2 makes a hydrogen bond with the main chain carbonyl oxygen of Ala874 of L3BR. The center of the BRCT–
BRCT interface (H region) is contributed by hydrophobic
side chains from each subunit that form an interdomain hydrophobic core (Figure 1D). X1BR2 Leu539 appears critical for this hydrophobic core by virtue of extensive hydrophobic interactions with Leu847, Tyr871, Ala874 and
Phe875 of L3BR. In addition, Leu539 main-chain amide
hydrogen bonds with the Tyr871 side-chain of L3BR. Similarly, L3BR Leu847 makes hydrophobic interactions with
XRCC1 residues Leu539, Tyr565 and Phe569. Finally, in
the P region, Arg870 of L3BR makes hydrogen bonds with
the side-chain amide of Asn570 and the main-chain carbonyl oxygens of Leu539 and Ala568 in X1BR2 (Figure 1D,
P region).
X1BR2 N-stretch and ␣1 are critical for XL heterodimerization
To test the structurally-implicated critical roles of the E,
H and P regions in XL heterodimerization, a series of
amino acid substitutions were introduced into all three regions of the XLBR-BR interface (Figure 1E). Substitutions
of Leu539 from the N-stretch of X1BR2 with Ala or Glu
completely disrupted complex formation with L3BR as detected by native gel electrophoresis (Figure 1E). This reveals the functional importance of this region extending
from the BRCT core and also supports and extends the previous finding that the N-terminal segment of X1BR2 significantly expands the buried surface area upon binding to
L3BR (48). In contrast, L3BR Leu847, a structural equivalent of Leu539 in the N-stretch of XRCC1, appears to be
dispensable for XL complex formation (Figure 1E), despite
the similar appearance of both Leu residues and their local interactions with either side of the dimer interface. Although contradictory to a previous report (48), this is consistent with the dispensable role of the N-terminal linker of
L3BR for XRCC1 binding and is indicative of functional
asymmetry in this heterotypic BRCT–BRCT interaction.
Given the dispensable role of L3BR Leu847, the severe defect in the X1BR2 Y565A/F569A double mutant (Figure
1E) is likely to be explained by some other interaction, perhaps a change in packing between XRCC1 helices ␣1 and ␣3
due to the replacement of bulky aromatic side chains. While
X1BR2 Y565A, F569A and N570A mutants exhibited little or no effect on complex formation with L3BR (Figure
1E), the R560A, R564A and R560A/R564A mutants either failed to or had greatly diminished ability to form complexes with L3BR. Taken together, these mutational analyses defined specific hydrophobic interactions involving the
N-stretch (Leu539) of XRCC1 and corresponding surfaces
of LigIII␣, along with electrostatic interactions between ␣1s
from XRCC1 (Arg560 and Arg564) and LigIII␣, as key determinants of XRCC1–LigIII␣ heterodimer formation.

Downloaded from https://academic.oup.com/nar/article/49/1/306/6039925 by Washington University School of Medicine Library user on 27 February 2021

magnetic beads in complex with a GFP-labeled X1BR2
domain. The release of the X1BR2–GFP protein into the
supernatant was monitored by the increase in GFP fluorescence as MBP-tagged L3BR832 protein was added to
the binding reaction for competition. In this competition
binding assay (Figure 1B), L3BR844 shows a slightly higher
X1BR2-binding affinity than L3BR832 (EC50 values of 0.67
± 0.08 and 1.24 ± 0.06 M for L3BR844 and L3BR832 ,
respectively), whereas MBP alone showed no interaction
(Supplementary Figure S3). Together, we conclude that
LigIII␣ and XRCC1 specifically heterodimerize with subto low micromolar affinity through their C-terminal BRCT
domains, and the N-terminal linker of L3BR contributes
to the determination of homodimer and heterodimer formation, prompting us to further investigate the interface of
human XL heterodimer and to identify key determinants of
the specific XL complex formation.
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Atypical asymmetric BRCT–BRCT interaction promotes XL
heterodimerization

Full-length XRCC1 and LigIII␣ form transient homodimers
with a largely unstructured multi-domain architecture
Apart from ordered X1BR1, X1BR2 and N-terminal domains (Figure 1A), XRCC1 appears unstructured. To experimentally examine the intrinsic flexibility of the fulllength human XRCC1, we used SAXS (77,78) and SECSAXS-MALS. SEC-SAXS analysis of individual SAXS
profiles across the elution peak revealed a large decrease
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The ␣1 helices of X1BR2 and L3BR domains share a
remarkable sequence similarity (50% identity in ␣1 and
surrounding residues, versus 29% overall sequence identity for the whole BRCT domains; Supplementary Figure
S6), including similar patterns of charged and hydrophobic patches of surface residues around the dimer interface.
Given the pseudo two-fold symmetry of interacting subunits in the XLBR-BR heterodimer (Supplementary Figure
S6), this raises the question of why the XL heterodimer is
preferred over the L3BR homodimer (Supplementary Figure S2). To address this, we compared structures of our
XLBR–BR heterodimer to the X1BR2 homodimer (PDB ID:
1CDZ) (48) [2.4 Å resolution, r.m.s.d. of 0.8 Å for C␣
atoms]. The XLBR–BR complex deviates significantly from
strict 2-fold symmetry. Notably, the ␣1 of the L3BR subunit in the XL heterodimer is rotated ∼16◦ relative to the
corresponding ␣1 of X1BR2 in the homodimer, as a result
of different inter-subunit contacts in the two complexes with
L3BR Arg870 acting as a pivot point for this conformational rotation (Supplementary Figure S6).
In the E region, ␣1 rotation causes a 3 Å displacement
of L3BR Asp849 side chain with respect to Asp541 in the
X1BR2 homodimer. Notably, this change results in a new
salt bridge between X1BR2 Arg564 and L3BR Asp849 in
the XL heterodimer (Figure 1D) that is essential for heterodimerization. In addition, L3BR Asp876 stands in for
X1BR2 Asn570, completing the salt bridge network in the
XL heterodimer (Figure 1D, E region). In the H region, the
rotated BRCT conformation in the XL dimer appears to
strengthen the X1BR2 Leu539-L3BR Tyr871 interaction,
based on the closer distance (3.3 Å) in the XL heterodimer
compared to the Leu539–Tyr565 interaction in the X1BR2
homodimer (3.9 Å) (Figure 1D). In contrast to the E and H
regions, interactions in the P region of the XL heterodimer
are diminished compared to the P region of the X1BR2 homodimer. For example, unlike Arg560 in the X1BR2 homodimer, L3BR Ser866 in the XL complex is unable to
make interactions with Asn570 and Glu572 of the X1BR2
subunit (Figure 1D and E, and Supplementary Figure S6).
The asymmetric XL structure explains the functional
asymmetry between the essential role of X1BR2 Leu539
and the dispensable role of L3BR Leu847 (Figure 1E). This
asymmetry may provide flexibility in the L3BR N-stretch
to allow the rotated conformation of L3BR upon X1BR2
binding. Collectively, the asymmetry induced by conformational rotation of L3BR contributes to favorable XL heterodimerization by strengthening the two crucial interactions mediated by Leu539 and Arg564 of X1BR2 in the XL
heterodimer (Figure 1D and E).

of Rg (65–45 Å) and molecular mass (110–70 kDa) (Figure 2A). This indicates heterogeneity within the sample that
presumably reflects transient dimerization of XRCC1 (49).
The Kratky plot (Figure 2B) from the merged SAXS curve
(Supplementary Figure S7A), together with the P(r) functions (Figure 2C), demonstrate that XRCC1 is a partially
unfolded, multidomain scaffold-like protein with an estimated maximal elongation of ∼230 Å that matches the
value estimated from analytic sedimentation equilibrium
studies (49).
As phosphorylation of the region between X1BR1–
X1BR2 by casein kinase II (CK2) stabilizes the protein and
is required for localization to DNA damage foci and efficient SSBR activity (30,34,79) we purified XRCC1N after
co-expression with CK2␣ in E. coli (80). In comparison with
unmodified XRCC1N, we found that phosphorylation
of XRCC1N does not alter its binding activity towards
L3BR (Supplementary Figure S8) or its solution conformation, based on the nearly identical SAXS profiles of phosphorylated and unphosphorylated XRCC1N (Figure 2B).
The P(r) curve for XRCC1N-p exhibits a gradual fall off
at high R-values that is indicative of a large Dmax (∼200
Å). The radius of gyration (Rg = 53 Å) is also unexpectedly large for the 340-residue XRCC1N-p protein (Figure
2C) and, similar to full length XRCC1, XRCC1N-p is a
mixture of monomers and dimers in solution as judged by
estimated molecular mass (59) (Supplementary Table S2).
Collectively, these experimental data are consistent with a
transient dimerization of XRCC1 via the X1BR2 domains.
To explore the conformational space that can be occupied
by XRCC1, we performed rigid body modeling that was validated by SAXS fitting. Initially we determined the atomistic model of XRCC1N by connecting the NMR structure of X1BR1 (PDB ID: 2D8M) and the crystal structure
of X1BR2 (see Materials and Methods). A selected minimal
ensemble model (Figure 2D), that includes 40% extended
monomer, 35% extended dimer and 25% compact dimer,
was the best fit for the experimental SAXS profile and P(r)
function (Figure 2C and Supplementary Figure S7A). Next,
we modeled full length XRCC1 by connecting the NMR
structure of XRCC1 N-terminal domain (PDB ID: 1XNA)
(62) to the XRCC1N model. An ensemble model (Figure
2E) that includes 61% extended monomer, 14% extended
dimer and 25% compact dimer closely matched the experimental SAXS profile and P(r) function (Figure 2B and C,
and Supplementary Figure S7A). While these ensembles do
not provide a unique model, they validate the intrinsically
disordered nature and transient dimerization of XRCC1.
To gain insights into the structure of full-length human LigIII␣, we initially determined a solution state of
the L3BR832 . Based on the estimated molecular mass and
SAXS fitting of rigid body modeling, the solution structure
model for L3BR832 closely matches the two-fold symmetric
homodimer of L3BR (PDB ID: 3PC7) (Figure 3A and Supplementary Figure S7C, Table S2). The results of the Kratky
plot (Figure 3B) and the P(r) function (Figure 3A) analyses of full-length LigIII␣ indicate that, like LigIII␤ (63),
LigIII␣ has a disordered multidomain architecture. Unlike
the L3BR domain that is exclusively dimeric in solution
(Supplementary Figure S7C, Table S2), full-length LigIII␣
is a mixture of monomer and dimers in solution, with max-
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imal elongation of ∼200 Å (Figure 3C and Supplementary
Figure S7B, Table S2). A comparison of normalized Kratky
plots of LigIII␤ with LigIII␣ indicates a similar level of
protein disorder (Figure 3B) despite Lig III␤ behaving as
a monomer due to the absence of the L3BR domain (63).
As expected (63), a comparison of LigIII␤ (LigIII␤ 1–755)
missing the disordered C-terminal 107 residues and LigIII␤
missing the N-terminal ZnF domain (LigIII␤ 1–755 ZnF)
(Figure 3B) confirmed the significant contribution of the
ZnF region to the disordered character of LigIII␤ (63). Together, our rigid body modeling analysis indicates that the
N- terminal ZnF extension and the C-terminal BRCT domain of LigIII␣, contribute significantly to the elongated
shape of the DNA ligase III polypeptides.
Visualization of XL complex by negative stain electron microscopy reveals a loosely packed domain arrangement
To gain insights into the possible domain organization of
the XL complex, we co-purified the full-length proteins
and confirmed that they form a ∼180 kDa heterodimer by
SEC-MALS despite eluting earlier than expected from the
gel filtration column (Figure 4A and B). XRCC1 and the
XL complex were each stabilized with chemical crosslink-

ing (Figure 4C), buffer exchanged and visualized using
negative-stain EM. Micrograph quality was greatly improved by the crosslinking and subsequent buffer exchange
steps (Supplementary Figure S9). Yet, 2D classification of
the single particles from the XRCC1 sample revealed a conformationally heterogenous population of XRCC1 (Figure
4D) that is, based on our SAXS data (Figure 2A), likely to
reflect a mixture of monomers and dimers. Crosslinking did
not reduce this heterogeneity (data not shown). Efforts to
generate an initial 3D model of XRCC1 failed, probably due
to its intrinsic structural and oligomeric heterogeneity. Despite efficient crosslinking, classes of particles representing
XRCC1-only particles were detected in the population of
particles from the XL sample (Figure 4E). After removal of
the XRCC1-only particles, the uniformly-sized XL particles
(Figure 4F) were subjected to 3D classification to identify
conformationally different forms of the XL complex (Supplementary Figure S10). Particles belonging to two visually similar classes were pooled and used to refine EM conformer 1. Particles from a third class were used to create EM
conformer 2 (both conformers shown in Figure 4G).
Some structural heterogeneity for the XL complex was
expected given the flexible and dynamic nature of both
proteins. The conformers presented here do not repre-
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Figure 2. Human XRCC1 is an elongated, disordered protein that transiently forms homodimers. (A) SEC-SAXS-MALS chromatographs for XRCC1.
Solid lines represent the UV 280 nm (light magenta) or SAXS signal (magenta) in arbitrary units, while symbols represent molecular mass (light magenta)
and Rg values for each collected SAXS frame (magenta) versus elution time. The SEC-SAXS-MALS results, which show full-length XRCC1 is a mixture of
monomer/dimer, are representative of at least two independent preparations of XRCC1. (B) Normalized Kratky plot of XRCC1 (magenta) in comparison
with XRCC1N-p (dark green) and XRCC1N (light green). (C) Normalized P(r) functions of XRCC1 (magenta) in comparison with XRCC1N-p
(dark green) matching theoretical P(r) functions of atomistic models (black) shown in panels D and E. Weighted ensemble atomistic model shown in
molecular surface representation were used to fit experimental SAXS curves for XRCC1N-p (D) and XRCC1 (E) shown in Supplementary Figure S7A
and represented as theoretical P(r) functions in panel C.
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sent definitive models of domain organization, but rather
present a framework for modelling potential domain arrangements. Although other conceivable domain configurations might also be consistent with the EM results, our domain docking EM map interpretation was guided by known
crystal structures of LigIII␣ domains and our insights into
the conformation of XRCC1 alone from 2D classes (Figure
4D). The XRCC1 monomer often adopts a linear arrangement that can be observed in both EM conformers (Figure 4G). The published atomic coordinates of individual
XRCC1 domains were docked within this linear protrusion
so as to have the N-terminal domain (XRCC-N) distal to
the rest of the complex and the L3BR–X1BR2 heterodimer
at the interface with the remaining volume. At the other side
of the complex, we interpreted the isolated spherical density as the LigIII␣ ZnF. Linking the two sides of the complex would be the LigIII␣ catalytic fragment composed of
the DNA binding, adenylation and OB-fold domains (63).
These conserved domains are known to adopt an open conformation, as seen for the Saccharolobus solfataricus DNA
Ligase (81) as well as a closed conformation with nicked
DNA (63). The EM map for conformer 1 accommodates the
catalytic domains in an approximately open conformation
whereas a more compact LigIII␣ is a better fit for the wider
volume seen in conformer 2. Overall, our interpretation of

two EM maps suggest a dynamic LigIII␣ catalytic fragment
that in turn orients XRCC1 at different positions within the
complex. The full dynamics of XRCC1 are probably underestimated due to limitations in visualizing unstructured
linkers by EM. However, the observed conformers allowed
us to build a framework of domains upon which we added
quantitative assessment of flexibility by SAXS as described
below.
The XL complex is more structured and compact than
XRCC1 and LigIII␣
Prior to investigating the solution structure of full-length
XL, we determined that the interaction of L3BR832 with
XRCC1N-p did not change the extended shape of
XRCC1N as judged by the Kratky plot, P(r) function
and SAXS parameters of the complex (Dmax of ∼200 Å
and Rg of 54 Å (Figure 5A and B, Supplementary Table
S2). We then examined the conformational flexibility of the
full-length XL complex by performing SEC-SAXS-MALS
experiments (Supplementary Figure S7D). Consistent with
Figure 4A, the major peak eluting from the gel filtration
column corresponded to the XL heterodimer, as judged
by molecular estimates from MALS and SAXS (Supplementary Figure S7D, Table S2). The decrease of Rg val-

Downloaded from https://academic.oup.com/nar/article/49/1/306/6039925 by Washington University School of Medicine Library user on 27 February 2021

Figure 3. Human LigIII␣ is an elongated, disordered protein that transiently forms homodimers. (A) Normalized P(r) functions for experimental SAXS
curves for full length LigIII␣ (cyan) and L3BR (green) are fitted to the theoretical P(r) functions (black) of atomistic models of full length LigIII␣ (panel
C) and the two-fold symmetric crystal structure of the L3BR homodimer (PDBID: 3PC7, black dots) and L3BR monomer (red). (B) Comparison of
normalized Kratky plots of LigIII␣ (cyan), L3BR dimer (green) with the SAXS curves of LigIII␤ (dark violet), LigIII␤ 1–755 (violet), and LigIII␤ 1–755
ZnF (dark green) (taken from (63)). Kratky plots show persistent disorder of full length LigIII␣ and LigIII␤ but significant less disorder in the LigIII␤
construct with truncated ZnF domain. (C) Weighted ensemble atomistic models of LigIII␣ monomer (left) and homodimer (right) are shown in surface
representation. Corresponding fits of the SAXS curves for the atomistic models are shown in the Supplementary Figure S7D and as a theoretical P(r)
function in panel A.
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Figure 4. Visualization of XL particles by electron microscopy reveals a dynamic domain arrangement. (A) SEC-MALS analysis shows that XRCC1 either
alone or in complex with full-length LigIII␣ elutes earlier than globular protein standards despite molar masses of ∼77 and ∼180 kDa, respectively. (B) The
XL peak seen in (A) is composed of a heterodimer. (C) The XL dimer was chemically crosslinked prior to negative-stain EM imaging. (D) 2D classification
reveals oligomeric and conformational heterogeneity in non-crosslinked XRCC1. (E) Particles belonging to non-XL 2D classes were removed from the
cross-linked XL dataset. (F) The final dataset contained uniformly-sized 2D classes of particles. 3D classification and subsequent refinement resulted in
two conformers of the XL complex. (G) The 3D EM maps are rotated to each display a linear protrusion from a larger area of density. The linear extension
potentially represents XRCC1 domains X1BR2 (PDB ID: 3PC8 chain A), X1BR1 (PDB ID: 2D8M) and the N-terminus (PDB ID: 3K77). The LigIII␣
ZnF (PDB ID: 1UW0), three domain catalytic fragment (DBD, NTase and OBD, PDB ID: 3L2P) and L3BR (PDB ID: 3PC8 chain C) domains were
docked into the larger area of density of each conformer.
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cessible for additional protein-protein interactions with the
flexible N-terminal nick sensing region of LigIII␣.
DISCUSSION
Based on previous studies, both XRCC1 and LigIII␣
are elongated proteins composed of some well-folded domains connected by flexible, unstructured regions (2,49,63).
While there is atomic resolution structural information for
the well-folded domains (39,48,62,63,82,83), less is known
about the functional architecture of the full length proteins,
particularly the XL complex that plays a key role in coordinating base excision and single strand break repair (84,85).
Accurate structural analyses of large and flexible complexes
can require combined approaches to assess both flexibility
(by SAXS), shape (by SAXS and EM) and detail (by Xray crystallography and NMR) (86,87). Here we integrated
results of crystallographic, EM and SAXS experiments for
LigIII␣ and XRCC1 with existing structural information
(39,48,62,63,82,83) to build a complete data-based model
of the highly flexible XL heterodimer that is anchored by a
unique BRCT–BRCT interaction (Figures 4 and 5).
XRCC1 and LigIII␣ BRCT domains are critical for
the stability and function of nuclear LigIII␣ (29,42,44).
Yet, XRCC1 has LigIII␣-independent functions in nuclear
DNA repair (42,44,45). Furthermore, the essential function of LigIII␣ in mitochondrial DNA metabolism occurs
in the absence of XRCC1 and is not dependent upon its
C-terminal BRCT domain (21,23,47). In accord with published studies concluding that the C-terminal BRCT domains also homodimerize (48,49), we observed formation
of XRCC1 and LigIII␣ homodimers albeit to a lesser extent than XL heterodimers. Overall, our atomic resolution
structure of the human BRCT–BRCT heterodimer closely
resembles that formed by mouse X1BR2 with human L3BR
and supports and extends the notion that interactions with
the region N-terminal to X1BR2 contribute to the preferred
formation of hetero- versus homodimers (48). However,
differences between the human and mouse-human hybrid
structures including an increase in the tilt angle between
the X1BR2 with L3BR domains in the human structure evidently reflect differences in the amino acids contributing to
the interaction interface. Residue substitutions confirmed
the key role of specific amino acids in the structurallydefined interface. They furthermore highlighted the structural and functional asymmetry, in particular rotation of
L3BR ␣1 helix in the XL heterodimer relative to the corresponding ␣1 helix of X1BR2 in the homodimer (48), that
seems to favor heterodimer formation.
While the XL complex is flexible, it is significantly more
compact than either XRCC1 or LigIII␣ (Figure 5A). The
linker region between the X1BR1 and X1BR2 domains
is extensively phosphorylated by CK2, enhancing interactions with PNKP and APTX via their FHA domains
(30,33,80,88). However, CK2 phosphorylation had no detectable effect on XRCC1 conformation. Since the catalytic
region of LigIII undergoes a large conformational change
when it engages nicked DNA (50), we examined the effect
of complex formation with XRCC1 on the LigIII catalytic
region. Notably, it was much more resistant to proteolysis
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ues determined for individual SAXS frames across the elution peak (Figure 5C) suggests XL conformational heterogeneity through transient interactions between multiple XL domains. However, the Kratky plots revealed significant compaction of the XL heterodimer relative to the
XRCC1 dimer (Figure 5A), consistent with the reduced heterogeneity the XL particles compared with XRCC1 particles seen by EM. To determine whether the compaction
extends beyond the interacting C-terminal BRCT domains
in the XL complex, we examined the protease-sensitivity
of labeled, adenylated LigIII. Notably, the labeled catalytic
fragment of LigIII was more resistant to proteolysis when
complexed with XRCC1 (Supplementary Figure S11), suggesting that the BRCT–BRCT heterodimer interacts with
and influences the conformation of the LigIII catalytic
region.
To test how the EM conformers 1 and 2 (Figure 4G)
match the solution state, we compared models based on the
available atomic structures that do not include the linker regions between domains to the SAXS curve. Without linker
regions that are missing from the atomic resolution structures, fits of the EM models were poor (χ 2 conformer1 = 11.6
and χ 2 conformer2 = 15.1, see Supplementary Figure S7E). To
determine whether this discrepancy was due to the flexibility
of the missing regions, these sections were built using MODELLER (61) and conformational sampling was applied using BILBOMD (65) to mimic the flexibility of the added regions (Supplementary Figure S12). While the SAXS fit was
improved by including linker flexibility (χ 2 conformer1 = 2.6
and χ 2 conformer2 = 3.0), the remaining discrepancy between
theoretical and experimental SAXS curves in the low resolution range of SAXS (q 0.05–0.15 Å−1 , see Figure 5C)
suggested larger conformational rearrangements of the XL
domains in solution. Closer inspection of the EM-derived
models showed that the N-terminal domain of XRCC1 and
the LigIII N-terminal ZnF domain are spatially separated
from the XL core (X1BR1, X1BR2, L3BR and LigIII catalytic domains) (Figure 4G). Thus, we performed rigid body
modeling that included flexibility of the N-terminal domains of XRCC1 and LigIII using EM conformers 1 and 2,
respectively as initial models. From approximately 10,000
conformers derived by conformational sampling (Supplementary Figure S7F), a multistate model containing two
conformers was selected by MultiFOXS (68) (Figure 5D
and Supplementary Figure S12). Displacement of the Nterminal domain of XRCC1 and the LigIII N-terminal ZnF
domain from their initial locations (Figure 5D and Supplementary Figure S12) significantly improved the SAXS fit
(χ 2 conformer1 = 1.6 and χ 2 conformer2 = 1.7, Figure 5C) in the
low-resolution range, in accord with the flexibility of these
regions inferred by our EM studies and shown by others
(49,50) (Figure 5D and Supplementary Figure S12). Notably, the most dominant conformers in both conformational samplings (Figure 5D) adopted a similar arrangement to the EM-derived conformers. Taken together, the
SAXS-derived model of full-length XL supports the domain arrangement predicted by EM in which the BRCT–
BRCT heterodimer is the stable core of the XL complex that
increases the compaction of the LigIII catalytic region and
links the flexible N-terminal regions of XRCC1 that are ac-
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Figure 5. Increased XL compaction from comparison of EM and SAXS results. (A) Normalized Kratky plot of XRCC1 (magenta) in comparison with
XRCC1N-p/L3BR (blue) and XL complex (red) revealed compaction of larger XL complexes. The SAXS profiles are representative of two independent
experiments. (B) Normalized P(r) functions obtained for experimental SAXS shown in panel A fitted to the theoretical P(r) functions (black) of atomistic
models of XRCC1 (Figure 2E) and the multistate model of XL complex derived from the EM conformer 1 shown in panel D. P(r) function of XRCC1Np/L3BR complex reveal that the XRCC1N has an elongated, flexible conformation, even when bound to L3BR domain. (C) Experimental (black) and
theoretical (colored as indicated) SAXS profiles for the two XL EM conformers with optimized conformations of the linker regions (red and magenta) and
optimized locations of the N-terminal domain of XRCC1 and the LigIII N-terminal ZnF domain (XRCC-N, cyan and ZnF, green). SAXS fits are shown
together with the fit residuals in the lower panel and χ 2 values indicating goodness of fit. (D) The top weighted model from the multistate SAXS-model
of XL complex was modelled using EM conformer 1 (top) and conformer 2 (bottom) as initial model. Both conformers of multistate models are shown in
Supplementary Figure S12. Models are superimposed on to the 3D EM maps. Corresponding SAXS fits for the atomistic models are shown in panel C and
further shown as a theoretical P(r) functions in panel B. XRCC1 is constitutively phosphorylated by CK2 (30), and the phosphorylation site is indicated
by P within a green circle. Interacting regions of XRCC1 with partner proteins are indicated.
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DATA AVAILABILITY
Coordinates and structure factors have been deposited in
the PDB with accession codes 6WH1 for the XLBR-BR
complex and 6WH2 for X1BR2. The EM maps have been
deposited in the EMDB with accession codes 22130 and
22307 for EM conformer 1 and EM conformer 2, respectively. SAXS data and atomistic models of XRCC1N-p,
XRCC1, LigIII␣ and XL complex have been deposited in
the SASBDB with accession codes SASDJ52, SASDJ62,
SASDJ72 and SASDJ82.
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